Department of Pathology & Laboratory Medicine, Tufts Medical Center, Boston, MA, USA.
Department of Pathology & Laboratory Medicine, University of Missouri-Kansas City, Kansas City, MO, USA.
Int J Surg Pathol. 2023 Aug;31(5):592-595. doi: 10.1177/10668969221108747. Epub 2022 Jul 18.
MiT family translocation renal cell carcinomas harbor gene fusion involving members of MiT family of transcription factors. Their precursor lesions have not been identified. Herein, we report the first case of small papillary tumors morphologically resembling papillary adenomas but harboring gene alteration. The patient was a 23-year old man with multiple small papillary tumors in the right kidney discovered following a gunshot wound injury. These lesions were < 5 mm, well-circumscribed but not encapsulated tubulopapillary proliferation lined with a single layer of cuboidal cells with WHO/ISUP grade 1 or 2 nuclei. The tumor cells were immunoreactive to PAX8, AMACR, high molecular weight cytokeratin, and keratin 7 and negative for CD10, CA9, TTF1, and cathepsin K. Morphologically and immunohistochemically, these lesions were diagnosed as papillary adenomas. gene rearrangement was confirmed by fluorescence in-situ hybridization (FISH) using a break-apart probe. We term these tumors "papillary adenoma-like" renal tumor with TFE3 gene rearrangement. These tumors are likely a precursor to or represent an early event in the development of translocation renal cell carcinomas. An understanding of such tumors to translocation renal cell carcinoma progression can provide insight into the pathogenic mechanism, and ultimately aid the diagnosis and management of translocation renal cell carcinoma.
MiT 家族易位性肾细胞癌具有涉及 MiT 家族转录因子成员的基因融合。其前体病变尚未确定。本文报告首例形态上类似于乳头状腺瘤但具有 基因改变的小乳头状肿瘤。患者为 23 岁男性,因枪伤后发现右肾多发性小乳头状肿瘤。这些病变<5mm,边界清楚但无包膜,呈管状乳头状增生,内衬单层立方细胞,核为 WHO/ISUP 分级 1 或 2 级。肿瘤细胞对 PAX8、AMACR、高分子量细胞角蛋白和角蛋白 7 呈免疫反应性,而对 CD10、CA9、TTF1 和组织蛋白酶 K 呈阴性。这些病变在形态学和免疫组化上被诊断为乳头状腺瘤。荧光原位杂交(FISH)使用断裂探针证实了 基因重排。我们将这些肿瘤命名为“具有 TFE3 基因重排的乳头状腺瘤样肾肿瘤”。这些肿瘤可能是 易位性肾细胞癌的前体,或者代表其发生的早期事件。了解此类肿瘤向易位性肾细胞癌的进展可以深入了解发病机制,并最终有助于易位性肾细胞癌的诊断和治疗。